Published in J Am Coll Cardiol on December 11, 2006
Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative. Eur Heart J (2009) 3.52
Design, synthesis, and actions of a novel chimeric natriuretic peptide: CD-NP. J Am Coll Cardiol (2008) 2.04
Cardiac surgery-associated acute kidney injury. Cardiorenal Med (2013) 1.26
Prevention and treatment of acute kidney injury in patients undergoing cardiac surgery: a systematic review. Am J Nephrol (2010) 1.23
Targeting the kidney in acute heart failure: can old drugs provide new benefit? Renal Optimization Strategies Evaluation in Acute Heart Failure (ROSE AHF) trial. Circ Heart Fail (2013) 1.21
Pharmacological therapies for the prevention of acute kidney injury following cardiac surgery: a systematic review. Heart Fail Rev (2011) 1.12
Mortality reduction in cardiac anesthesia and intensive care: results of the first International Consensus Conference. HSR Proc Intensive Care Cardiovasc Anesth (2011) 1.11
The effects of nesiritide on renal function and diuretic responsiveness in acutely decompensated heart failure patients with renal dysfunction. J Card Fail (2008) 1.08
Natriuretic peptides in cardiovascular diseases: current use and perspectives. Eur Heart J (2013) 1.08
AKI associated with cardiac surgery. Clin J Am Soc Nephrol (2014) 1.08
Peri-operative renal protection: The strategies revisited. Indian J Urol (2012) 1.06
Chronic actions of a novel oral B-type natriuretic peptide conjugate in normal dogs and acute actions in angiotensin II-mediated hypertension. Circulation (2008) 1.04
Pharmacodynamics of a novel designer natriuretic peptide, CD-NP, in a first-in-human clinical trial in healthy subjects. J Clin Pharmacol (2009) 1.02
Local renal delivery of a natriuretic peptide a renal-enhancing strategy for B-type natriuretic peptide in overt experimental heart failure. J Am Coll Cardiol (2009) 1.00
Vasodilators in the treatment of acute heart failure: what we know, what we don't. Heart Fail Rev (2008) 0.97
Cardiovascular and renal effects of carperitide and nesiritide in cardiovascular surgery patients: a systematic review and meta-analysis. Crit Care (2011) 0.97
Degradation of the endothelial glycocalyx in clinical settings: searching for the sheddases. Br J Clin Pharmacol (2015) 0.91
Cardiac surgery-associated acute kidney injury. J Anesth (2012) 0.90
Perioperative acute kidney injury. Perioper Med (Lond) (2012) 0.90
Modulation of cGMP in heart failure: a new therapeutic paradigm. Handb Exp Pharmacol (2009) 0.88
The tumultuous journey of nesiritide: past, present, and future. Circ Heart Fail (2008) 0.87
Risk factors for endotracheal re-intubation following coronary artery bypass grafting. J Cardiothorac Surg (2013) 0.86
Acute kidney injury clinical trial design: old problems, new strategies. Pediatr Nephrol (2012) 0.86
Early intervention in acute kidney injury. Nat Rev Nephrol (2010) 0.85
Role of guanylate cyclase modulators in decompensated heart failure. Heart Fail Rev (2009) 0.84
Cardiac surgery-associated acute kidney injury. Ann Card Anaesth (2016) 0.83
Long-term effects of B-type natriuretic peptide infusion after acute myocardial infarction in a rat model. J Cardiovasc Pharmacol (2010) 0.83
Renal and anti-aldosterone actions of vasopressin-2 receptor antagonism and B-type natriuretic peptide in experimental heart failure. Circ Heart Fail (2010) 0.83
Management strategies for stage-D patients with acute heart failure. Clin Cardiol (2008) 0.82
The prevention of acute kidney injury an in-depth narrative review: Part 2: Drugs in the prevention of acute kidney injury. NDT Plus (2009) 0.81
Cardiorenal syndromes: pathophysiology to prevention. Int J Nephrol (2010) 0.81
Molecular and physiological effects of nesiritide. Can J Cardiol (2008) 0.79
Acute renal failure and cardiac surgery. HSR Proc Intensive Care Cardiovasc Anesth (2009) 0.79
Nesiritide in acute decompensated heart failure: current status and future perspectives. Rev Cardiovasc Med (2008) 0.78
Section 3: Prevention and Treatment of AKI. Kidney Int Suppl (2011) (2012) 0.78
Effect of rhBNP on renal function in STEMI-HF patients with mild renal insufficiency undergoing primary PCI. Heart Vessels (2015) 0.78
Nesiritide improves hemodynamics in children with dilated cardiomyopathy: a pilot study. Pediatr Cardiol (2008) 0.76
Serum creatinine role in predicting outcome after cardiac surgery beyond acute kidney injury. World J Cardiol (2014) 0.76
Preoperative usages of levosimendan in patients undergoing coronary artery bypass grafting. Int J Clin Exp Med (2014) 0.76
Nesiritide administration in patients with left ventricular dysfunction undergoing coronary artery bypass surgery. J Am Coll Cardiol (2006) 0.75
Efficacy and safety of nesiritide in patients with decompensated heart failure: a meta-analysis of randomised trials. BMJ Open (2016) 0.75
B-type natriuretic peptide: beyond a diagnostic. Heart Fail Clin (2008) 0.75
A patient with AKI after cardiac surgery. Clin J Am Soc Nephrol (2014) 0.75
From Pre-Existing Renal Failure to Perioperative Renal Protection: The Anesthesiologist's Dilemmas. Anesth Pain Med (2016) 0.75
A new signal from B-type natriuretic peptide in ST-elevation myocardial infarction: what does it mean for B-type natriuretic peptide and innovative diagnostics? Circulation (2010) 0.75
Atrial natriuretic peptide for the prevention of contrast-induced nephropathy: what's old is new but at the right dose and duration of therapy! J Am Coll Cardiol (2009) 0.75
Prolonged effects of B-type natriuretic peptide infusion on cardiac remodeling after sustained myocardial injury. Am J Physiol Heart Circ Physiol (2009) 0.75
Nesiritide: the clinical experience. Can J Cardiol (2008) 0.75
Nesiritide for acute decompensated heart failure. Rev Cardiovasc Med (2007) 0.75
Unexpected abrupt increase in left ventricular assist device thrombosis. N Engl J Med (2013) 6.33
Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Circulation (2007) 4.16
Radial artery bypass grafts have an increased occurrence of angiographically severe stenosis and occlusion compared with left internal mammary arteries and saphenous vein grafts. Circulation (2004) 4.13
Association between increases in urinary neutrophil gelatinase-associated lipocalin and acute renal dysfunction after adult cardiac surgery. Anesthesiology (2006) 3.66
Evidence-based guidelines for cardiovascular disease prevention in women. Circulation (2004) 3.39
Independent and incremental role of quantitative right ventricular evaluation for the prediction of right ventricular failure after left ventricular assist device implantation. J Am Coll Cardiol (2012) 3.17
Surgical ventricular restoration in the treatment of congestive heart failure due to post-infarction ventricular dilation. J Am Coll Cardiol (2004) 2.62
Myostatin activation in patients with advanced heart failure and after mechanical unloading. Eur J Heart Fail (2010) 2.40
Predictors of severe right ventricular failure after implantable left ventricular assist device insertion: analysis of 245 patients. Circulation (2002) 2.33
Resveratrol, a natural red wine polyphenol, reduces ischemia-reperfusion-induced spinal cord injury. Ann Thorac Surg (2005) 2.15
Influence of patient characteristics and arterial grafts on freedom from coronary reoperation. J Thorac Cardiovasc Surg (2005) 2.09
Does off-pump coronary surgery reduce morbidity and mortality? J Thorac Cardiovasc Surg (2002) 2.08
Right heart failure after left ventricular assist device implantation in patients with chronic congestive heart failure. J Heart Lung Transplant (2005) 2.05
A comparison of bivalirudin to heparin with protamine reversal in patients undergoing cardiac surgery with cardiopulmonary bypass: the EVOLUTION-ON study. J Thorac Cardiovasc Surg (2006) 2.00
Determination of brain death by apnea test adapted to extracorporeal cardiopulmonary resuscitation. J Cardiothorac Vasc Anesth (2012) 1.98
The cost of medical management in advanced heart failure during the final two years of life. J Card Fail (2008) 1.71
Predictors of long-term outcomes in symptomatic hypertrophic obstructive cardiomyopathy patients undergoing surgical relief of left ventricular outflow tract obstruction. Circulation (2013) 1.71
Clinical and economic burden of postoperative pulmonary complications: patient safety summit on definition, risk-reducing interventions, and preventive strategies. Crit Care Med (2011) 1.70
Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. J Am Coll Cardiol (2007) 1.69
Early risk of mortality after coronary artery revascularization in patients with left ventricular dysfunction and potential role of the wearable cardioverter defibrillator. Circ Arrhythm Electrophysiol (2012) 1.66
Mitral valve abnormalities in hypertrophic cardiomyopathy: echocardiographic features and surgical outcomes. Ann Thorac Surg (2008) 1.65
The impact of angiotensin-converting enzyme inhibitor therapy on the extracellular collagen matrix during left ventricular assist device support in patients with end-stage heart failure. J Am Coll Cardiol (2007) 1.63
Survival after heart transplantation is not diminished among recipients with uncomplicated diabetes mellitus: an analysis of the United Network of Organ Sharing database. Circulation (2006) 1.62
Surgery for permanent atrial fibrillation: impact of patient factors and lesion set. Ann Thorac Surg (2006) 1.59
Evidence-based guidelines for cardiovascular disease prevention in women. J Am Coll Cardiol (2004) 1.59
New-onset postoperative atrial fibrillation and long-term survival after aortic valve replacement surgery. Ann Thorac Surg (2010) 1.55
Major bleeding during HeartMate II support. J Am Coll Cardiol (2013) 1.55
Heart transplant and left ventricular assist device costs. J Heart Lung Transplant (2005) 1.55
Effect of donor age on long-term survival following cardiac transplantation. J Card Surg (2006) 1.54
New-onset postoperative atrial fibrillation after isolated coronary artery bypass graft surgery and long-term survival. Circ Cardiovasc Qual Outcomes (2009) 1.53
Bivalirudin during cardiopulmonary bypass in patients with previous or acute heparin-induced thrombocytopenia and heparin antibodies: results of the CHOOSE-ON trial. Ann Thorac Surg (2007) 1.53
Clevidipine compared with nitroglycerin for blood pressure control in coronary artery bypass grafting: a randomized double-blind study. Can J Anaesth (2014) 1.52
Outcomes of simultaneous liver transplantation and elective cardiac surgical procedures. Ann Thorac Surg (2011) 1.49
Evidence-based guidelines for cardiovascular disease prevention in women. American Heart Association scientific statement. Arterioscler Thromb Vasc Biol (2004) 1.49
Laser energy source in surgical atrial fibrillation ablation: preclinical experience. Ann Thorac Surg (2006) 1.47
Which patient, which pump? J Heart Lung Transplant (2003) 1.46
Long-term outcomes in high-risk symptomatic patients with hypertrophic cardiomyopathy undergoing alcohol septal ablation. JACC Cardiovasc Interv (2008) 1.44
Cardiac magnetic resonance detection of myocardial scarring in hypertrophic cardiomyopathy: correlation with histopathology and prevalence of ventricular tachycardia. J Am Coll Cardiol (2009) 1.44
Established preoperative risk factors do not predict long-term survival in isolated coronary artery bypass grafting patients. Ann Thorac Surg (2012) 1.44
Effects of surgical ventricular restoration on left ventricular function: dynamic MR imaging. Radiology (2006) 1.41
Totally endoscopic atrial septal defect repair with robotic assistance. Circulation (2003) 1.40
The impact of hypogammaglobulinemia on infection outcome in patients undergoing ventricular assist device implantation. J Heart Lung Transplant (2006) 1.40
Mechanical treatment of heart failure: the growing role of LVADs and artificial hearts. Cleve Clin J Med (2003) 1.40
Risk of not being discharged home after isolated coronary artery bypass graft operations. Ann Thorac Surg (2013) 1.40
Edge-to-edge (Alfieri) mitral repair: results in diverse clinical settings. Ann Thorac Surg (2004) 1.40
Surgical ventricular restoration: the RESTORE Group experience. Heart Fail Rev (2004) 1.37
Coronary artery bypass grafting in patients with low ejection fraction. Circulation (2005) 1.36
Is severe right ventricular failure in left ventricular assist device recipients a risk factor for unsuccessful bridging to transplant and post-transplant mortality. Ann Thorac Surg (2004) 1.34
Right ventricular dysfunction and organ failure in left ventricular assist device recipients: a continuing problem. Ann Thorac Surg (2002) 1.33
Robotic techniques improve quality of life in patients undergoing atrial septal defect repair. Ann Thorac Surg (2004) 1.29
Bridging to transplant with the HeartMate left ventricular assist device: The Columbia Presbyterian 12-year experience. J Thorac Cardiovasc Surg (2004) 1.23
Continuous flow left ventricular assist device outcomes in commercial use compared with the prior clinical trial. Ann Thorac Surg (2011) 1.21
Revised screening scale to predict survival after insertion of a left ventricular assist device. J Thorac Cardiovasc Surg (2003) 1.19
Association of device surface and biomaterials with immunologic sensitization after mechanical support. J Thorac Cardiovasc Surg (2008) 1.16
Pharmacology of sedative-analgesic agents: dexmedetomidine, remifentanil, ketamine, volatile anesthetics, and the role of peripheral mu antagonists. Crit Care Clin (2009) 1.14
Mechanical unloading during left ventricular assist device support increases left ventricular collagen cross-linking and myocardial stiffness. Circulation (2005) 1.14
Left ventricular assist device support normalizes left and right ventricular beta-adrenergic pathway properties. J Am Coll Cardiol (2005) 1.13
Guidelines for critical care medicine training and continuing medical education. Crit Care Med (2004) 1.11
Tracheal resection in the morbidly obese patient: the role of dexmedetomidine. J Clin Anesth (2006) 1.10
Mechanical unloading leads to echocardiographic, electrocardiographic, neurohormonal, and histologic recovery. J Heart Lung Transplant (2005) 1.10
Improved survival among ventricular assist device recipients with a concomitant implantable cardioverter-defibrillator. Heart Rhythm (2010) 1.10
Dexmedetomidine in the care of critically ill patients from 2001 to 2007: an observational cohort study. Anesthesiology (2010) 1.08
Duration of inotropic support after left ventricular assist device implantation: risk factors and impact on outcome. J Thorac Cardiovasc Surg (2006) 1.08
Pharmacology of sedative-analgesic agents: dexmedetomidine, remifentanil, ketamine, volatile anesthetics, and the role of peripheral Mu antagonists. Anesthesiol Clin (2011) 1.08
Does right thoracotomy increase the risk of mitral valve reoperation? J Thorac Cardiovasc Surg (2007) 1.07
Does robotic technology make minimally invasive cardiac surgery too expensive? A hospital cost analysis of robotic and conventional techniques. J Card Surg (2005) 1.07
Risk analysis of deep sternal wound infections and their impact on long-term survival: a propensity analysis. Ann Plast Surg (2008) 1.06
Migration of an amplatzer septal occluder device for closure of atrial septal defect into the ascending aorta with formation of an aorta-to-right atrial fistula. Am J Cardiol (2005) 1.05
Effect of left ventricular assist device infection on post-transplant outcomes. J Heart Lung Transplant (2009) 1.05
Cardiac surgery after mediastinal radiation: extent of exposure influences outcome. J Thorac Cardiovasc Surg (2007) 1.05
Preventing acute kidney injury after cardiac surgery. Curr Opin Anaesthesiol (2011) 1.05
Endovascular edge-to-edge mitral valve repair: short-term results in a porcine model. Circulation (2003) 1.04
A double-blind randomized trial: prophylactic vasopressin reduces hypotension after cardiopulmonary bypass. Ann Thorac Surg (2003) 1.03
Retracted Dexmedetomidine infusion is associated with enhanced renal function after thoracic surgery. J Clin Anesth (2006) 1.02
Assessment of hemostatic activation during cardiopulmonary bypass for coronary artery bypass grafting with bivalirudin: results of a pilot study. J Thorac Cardiovasc Surg (2005) 1.01
Implantation of a left ventricular assist device and the hub-and-spoke system in treating acute cardiogenic shock: who survives? J Thorac Cardiovasc Surg (2003) 1.01
Axial and centrifugal continuous-flow rotary pumps: a translation from pump mechanics to clinical practice. J Heart Lung Transplant (2013) 1.01
Effectiveness of atrial fibrillation surgery in patients with hypertrophic cardiomyopathy. Am J Cardiol (2004) 1.00
The effect of ischemic time on survival after heart transplantation varies by donor age: an analysis of the United Network for Organ Sharing database. J Thorac Cardiovasc Surg (2007) 1.00
A novel family-based intervention trial to improve heart health: FIT Heart: results of a randomized controlled trial. Circ Cardiovasc Qual Outcomes (2008) 1.00
Thoracic surgery workforce: snapshot at the end of the twentieth century and implications for the new millennium. Ann Thorac Surg (2002) 1.00
Endoscopic computer-enhanced mediastinal mass resection using robotic technology. Heart Surg Forum (2003) 0.98
Mechanical support for the failing cardiac allograft: a single-center experience. J Heart Lung Transplant (2003) 0.98
Suppression of murine cardiac allograft arteriopathy by long-term blockade of CD40-CD154 interactions. Circulation (2002) 0.98
Predictors and outcomes of continuous veno-venous hemodialysis use after implantation of a left ventricular assist device. J Heart Lung Transplant (2006) 0.97
Long-term survival and quality of life in cardiac surgical patients with prolonged intensive care unit length of stay. Ann Thorac Surg (2002) 0.96
beta(2)-Adrenergic stimulation attenuates left ventricular remodeling, decreases apoptosis, and improves calcium homeostasis in a rodent model of ischemic cardiomyopathy. J Pharmacol Exp Ther (2006) 0.96
Role of the Abiomed BVS 5000 device for short-term support and bridge to transplantation. ASAIO J (2004) 0.95
Bivalirudin provides rapid, effective, and reliable anticoagulation during off-pump coronary revascularization: results of the "EVOLUTION OFF" trial. Anesth Analg (2006) 0.95
Acute kidney injury in cardiac surgery. Curr Opin Anaesthesiol (2015) 0.94
Lessons learned from balloon aortic valvuloplasty experience from the pre-transcatheter aortic valve implantation era. J Interv Cardiol (2010) 0.94
Beating heart catheter-based edge-to-edge mitral valve procedure in a porcine model: efficacy and healing response. Circulation (2004) 0.94
Coregistered MR imaging myocardial viability maps and multi-detector row CT coronary angiography displays for surgical revascularization planning: initial experience. Radiology (2005) 0.93
Illness representations and psychological distress in patients undergoing coronary artery bypass graft surgery. Psychol Health Med (2007) 0.92
Use of the Alfieri edge-to-edge technique to eliminate left ventricular outflow tract obstruction caused by mitral systolic anterior motion. Ann Thorac Surg (2004) 0.92
Microwave ablation of atrial fibrillation during mitral valve operations. Ann Thorac Surg (2002) 0.92
Regional referral system for patients with acute mechanical support: experience at the Cleveland Clinic Foundation. ASAIO J (2006) 0.92
The effect of body mass index on survival following heart transplantation: do outcomes support consensus guidelines? Ann Surg (2010) 0.91